HA
HC Advisors’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,345
| Closed | -$238K | – | 83 |
|
|
2022
Q4 | $238K | Sell |
5,345
-6,790
| -56% | -$303K | 0.16% | 67 |
|
|
2022
Q3 | $341K | Buy |
12,135
+4,510
| +59% | +$127K | 0.23% | 57 |
|
|
2022
Q2 | $206K | Sell |
7,625
-50
| -0.7% | -$1.35K | 0.15% | 73 |
|
|
2022
Q1 | $261K | Sell |
7,675
-508
| -6% | -$17.3K | 0.17% | 70 |
|
|
2021
Q4 | $316K | Buy |
8,183
+2,694
| +49% | +$104K | 0.19% | 59 |
|
|
2021
Q3 | $296K | Sell |
5,489
-927
| -14% | -$50K | 0.19% | 60 |
|
|
2021
Q2 | $215K | Buy |
+6,416
| New | +$215K | 0.13% | 74 |
|
|
2021
Q1 | – | Sell |
-14,791
| Closed | -$259K | – | 92 |
|
|
2020
Q4 | $259K | Buy |
14,791
+2,210
| +18% | +$38.7K | 0.18% | 70 |
|
|
2020
Q3 | $187K | Buy |
+12,581
| New | +$187K | 0.15% | 70 |
|